Ilan Hadar - Chairman and CEO, Director at Silexion Therapeutics Corp

Insider Transactions and Holdings

Entity Type
Individual
Role
Chairman and CEO, Director
Issuer Symbol
SLXN, SLXNW on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Ilan Hadar since 09 Mar 2025

Holdings reported by Ilan Hadar for Silexion Therapeutics Corp

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Ordinary Shares 65,471 $159,749 $2.44 20 Feb 2026 Direct
Stock Option (right to buy Ordinary Shares) 956 $2,332 $2.44 20 Feb 2026 Direct Ordinary Shares 956

Transactions reported by Ilan Hadar for Silexion Therapeutics Corp

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.